Noetik tackles cancer trial failures with AI, featuring TARIO-2 model
Noetik is leveraging artificial intelligence to address the high failure rate of cancer clinical trials, which often result from poor patient-drug matching. During a recent discussion, CEO Ron Alfa and…
